Elsevier

Neuropeptides

Volume 31, Issue 4, August 1997, Pages 367-372
Neuropeptides

Synthesis and opioid binding activity of dermorphin analogues containing cyclic β-amino acids

https://doi.org/10.1016/S0143-4179(97)90073-1Get rights and content

Abstract

In the present work, eight conformationally constrained analogues of the μ specific opioid peptide dermorphin were synthesized by replacing D-Ala2 with stereoisomers of β-amino-cycloalkane or cycloalkene carboxylic acids. The resulting peptides were tested for their potency to μ and δ opioid binding sites of rat brain membranes labelled with [3H]Tyr1-D-Ala2-MePhe4-Gly-ol, [3H]DAMGO and [3H]lle5,6deltorphin, respectively. All of the new derivatives displayed highly attenuated binding to both receptor types, albeit the decrease in their potency seemed to be less in the case of δ binding. Trans position of the β-amino groups resulted in higher binding affinities than that of the corresponding cis isomers, the latter being more flexible than the former. It is concluded that conformational constraints caused either by a rigid ring structure or cis isomers instead of D-Ala2 in dermorphin-derived peptides are unfavourable for binding activity to either opioid receptors. We propose that interaction of the larger heptapeptide derivatives of dermorphins with the μ receptor is distinct from that of the tetrapeptide morphiceptin.

References (36)

  • RC Thompson et al.

    Cloning and pharmacological characterization of a rat μ opioid receptor

    Neuron

    (1993)
  • T Reisine et al.

    Molecular biology of opioid receptors

    Trends Neurosci

    (1993)
  • CK Surratt et al.

    μ opiate receptor

  • GW Pasternak

    Multiple μ opiate receptors: biochemical and pharmacological evidence for multiplicity

    Biochem Pharmacol

    (1986)
  • VJ Hruby et al.

    Binding and information transfer in conformationally restricted peptides

  • PW Schiller et al.

    Conformational Restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity

    J Med Chem

    (1991)
  • M Goodman et al.

    Peptidomimetics for drug design

  • T Yamazaki et al.

    Probing a molecular model of taste utilizing peptidomimetic stereoisomers of 2-aminocyclopentanecarboxylic acid methyl ester

    J Org Chem

    (1991)
  • Cited by (31)

    • Long-lasting, distinct changes in central opioid receptor and urinary bladder functions in models of schizophrenia in rats

      2011, European Journal of Pharmacology
      Citation Excerpt :

      Tyr-Gly-(NMe)PHe-Gly-ol,DAMGO was purchased from Bachem AG (Bubendorf, Switzerland). At the age of week 15 animals were sacrificed, their cerebral cortex and hippocampus were dissected (n = 4/group) and crude membrane fractions were prepared as described earlier (Bozu et al., 1997). Briefly, the brain areas were homogenized in 30 volumes (v/w) of ice-cold 50 mM Tris–HCl pH 7.4 buffer with a teflon-glass Braun homogenizer operating at 1500 rpm.

    • Pharmacology of a new tritiated endomorphin-2 analog containing the proline mimetic cis-2-aminocyclohexanecarboxylic acid

      2011, Peptides
      Citation Excerpt :

      It was also suggested that the incorporation of the cis-(1S,2R)ACPC2 induced low-energy conformations, topologically similar to those calculated for the cis isomer of morphiceptin. We earlier established that the replacement of d-Ala2 by the rigid structure of ACHC2 was unfavorable for opioid binding in the case of another μ-specific peptide ligand, dermorphin (H-Tyr-d-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) [4]. It was hypothesized that the receptor–ligand interactions of the heptapeptide dermorphin derivatives with the μ-opioid receptor are distinct from those of the tetrapeptide morphiceptin.

    View all citing articles on Scopus
    View full text